SOURCE: Patheon

June 11, 2014 11:00 ET

Lukas Utiger, DSM Fine Chemicals and DPx Holdings B.V. Integrated Offering, to Speak at Chemspec Europe

DURHAM, NC--(Marketwired - June 11, 2014) - Lukas Utiger, Ph.D., President of DSM Fine Chemicals and the key leader behind the DPx Holdings B.V. Integrated Offering, will participate in a panel discussion titled Pharma Outsourcing Best Practices at the 29th Annual Chemspec Europe exhibition in Budapest, Hungary, on Wednesday, June 18 at 2 p.m. and Thursday, June 19 at 11:30 a.m.

Dr. Utiger holds a Ph.D. in Chemical Engineering from the Imperial College of London, and has 25 years of pharmaceutical industry experience in management, research and pharmaceutical manufacturing.

He will participate in the Pharma Outsourcing Best Practices panel discussion on how to develop global outsourcing strategies, detect outsourcing partners, manage partnerships, minimize risks and address other outsourcing challenges. This panel discussion will appeal to pharmaceutical companies, contract research organizations and contract manufacturing organizations involved in research of Active Pharmaceutical Ingredients.

"The Chemspec Europe exhibition is a great opportunity to connect with our industry to share insight and best practices," shared Utiger. "I am looking forward to the panel discussion and what I can learn from others in the industry."

With more than 400 international companies represented at the exhibition, Chemspec Europe allows attendees to connect and network with manufacturers and suppliers from a variety of sectors. Exhibitor showcase presentations and conference sessions are offered throughout the exhibition to reveal the latest innovations in the industry.

Chemspec Europe is strictly a trade exhibition and only for professionals in the fine and specialty chemicals industry.

For more information, visit http://www.chemspecevents.com/europe/conference/pharma-outsourcing-panel-discussion.

About DPx Holdings B.V.
DPx Holdings B.V. is the privately held parent company of the Patheon, DSM Fine Chemicals and Banner Life Sciences businesses. The company is a leading provider of CDMO services, pharmaceutical products and products for other industries. DPx Holdings B.V. was founded in 2014 as a result of a deal between JLL Partners and Royal DSM. With a global headquarters in Durham, N.C., DPx Holdings B.V. has a footprint of more than 20 locations across North America, Europe, Latin America and Australia with more than 8,000 employees. DPx Holdings B.V. offers customers unsurpassed quality, integrated offerings and value through these three business units. For more information visit www.patheon.com/DPx.

About DSM Fine Chemicals
Announced in March 2014 as a business unit under DPx Holdings B.V., DSM Fine Chemicals provides active pharmaceutical ingredients (API) as well as agricultural and crop protection chemicals, intermediates and maleic anhydride product tree chemicals. The main focus is custom synthesis chemicals produced for the pharma and fine chemicals markets. 

Contact Information